Mollenhauer B - Search Results

1

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patients.

Zago E, Dal Molin A, Dimitri GM, Xumerle L, Pirazzini C, Bacalini MG, Maturo MG, Azevedo T, Spasov S, Gómez-Garre P, Periñán MT, Jesús S, Baldelli L, Sambati L, Calandra-Buonaura G, Garagnani P, Provini F, Cortelli P, Mir P, Trenkwalder C, Mollenhauer B, Franceschi C, Liò P, Nardini C; PROPAG-AGEING Consortium. Zago E, et al. Among authors: mollenhauer b. Sci Rep. 2022 Jan 25;12(1):1330. doi: 10.1038/s41598-022-05227-6. Sci Rep. 2022. PMID: 35079043 Free PMC article.

2

Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia.

Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, Brechlin P, Schindehuette J, Poser S, Wiltfang J, Otto M. Mollenhauer B, et al. Dement Geriatr Cogn Disord. 2006;22(3):200-8. doi: 10.1159/000094871. Epub 2006 Aug 7. Dement Geriatr Cogn Disord. 2006. PMID: 16899997

3

[Diagnosis and clinical therapy for Parkinson's disease].

Wenzel S, Mollenhauer B, Trenkwalder C. Wenzel S, et al. Among authors: mollenhauer b. Nervenarzt. 2006 Dec;77(12):1439-43. doi: 10.1007/s00115-006-2179-7. Nervenarzt. 2006. PMID: 17093957 Review. German.

4

Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.

Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Sixel-Döring F, et al. Among authors: mollenhauer b. Sleep Med. 2009 Apr;10(4):407-15. doi: 10.1016/j.sleep.2008.05.004. Epub 2008 Oct 21. Sleep Med. 2009. PMID: 18945638

5

Neurochemical biomarkers in the differential diagnosis of movement disorders.

Mollenhauer B, Trenkwalder C. Mollenhauer B, et al. Mov Disord. 2009 Jul 30;24(10):1411-26. doi: 10.1002/mds.22510. Mov Disord. 2009. PMID: 19412961 Review.

6

Affective and cognitive Theory of Mind in patients with parkinson's disease.

Bodden ME, Mollenhauer B, Trenkwalder C, Cabanel N, Eggert KM, Unger MM, Oertel WH, Kessler J, Dodel R, Kalbe E. Bodden ME, et al. Among authors: mollenhauer b. Parkinsonism Relat Disord. 2010 Aug;16(7):466-70. doi: 10.1016/j.parkreldis.2010.04.014. Epub 2010 Jun 9. Parkinsonism Relat Disord. 2010. PMID: 20538499

7

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.

Mollenhauer B, El-Agnaf OM, Marcus K, Trenkwalder C, Schlossmacher MG. Mollenhauer B, et al. Biomark Med. 2010 Oct;4(5):683-99. doi: 10.2217/bmm.10.90. Biomark Med. 2010. PMID: 20945981 Review.

8

Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.

Mollenhauer B, Förstl H, Deuschl G, Storch A, Oertel W, Trenkwalder C. Mollenhauer B, et al. Dtsch Arztebl Int. 2010 Oct;107(39):684-91. doi: 10.3238/arztebl.2010.0684. Epub 2010 Oct 1. Dtsch Arztebl Int. 2010. PMID: 20963199 Free PMC article. Review.

9

CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.

Mollenhauer B, Esselmann H, Trenkwalder C, Schulz-Schaeffer W, Kretzschmar H, Otto M, Wiltfang J, Bibl M. Mollenhauer B, et al. J Alzheimers Dis. 2011;24(2):383-91. doi: 10.3233/JAD-2011-101551. J Alzheimers Dis. 2011. PMID: 21297274

10

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG. Mollenhauer B, et al. Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Lancet Neurol. 2011. PMID: 21317042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page